Articles From: The World's Sweetest Game Candy Crush Saga Debuts on Windows Phone to Thermo Fisher Scientific Strengthens Bioproduction Offering by Acquiring Advanced Scientifics, Inc.


2014/12/11
LONDON and NEW YORK , December 11, 2014 /PRNewswire/ -- King Digital Entertainment plc (NYSE: KING) , a leading interactive entertainment company for the mobile world, today announced its global hit game Candy Crush Saga is now available to download for free from the Windows Phone Store .
Sign-up for The World's Sweetest Game Candy Crush Saga Debuts on Windows Phone investment picks
2014/12/28
By Craig Stephen, MarketWatch HONG KONG (MarketWatch) -- Hong Kong's Hang Seng Index looks as if it could end 2014 pretty much where it started off.
Sign-up for The year the lid came off Hong Kong investment picks
2014/12/15
NEW YORK , Dec.
Sign-up for The Zweig Fund, Inc. Authorizes Declaration Of A Distribution investment picks
2014/12/15
NEW YORK , Dec.
Sign-up for The Zweig Total Return Fund, Inc. Authorizes Declaration Of A Distribution investment picks
2015/2/17
AMC Entertainment Holdings Inc. (AMC) said Tuesday that fourth-quarter net income was $29.8 million, or 30 cents a share, a share, compared with $279.6 million, or $3.58 a share, for the same period a year ago.
Sign-up for Theater chain AMC's earnings beat Q4 forecasts investment picks
2015/1/21
TheGrantLawFirm, PLLC announces that it has filed a class action suit in the United States District Court for the Southern District of New York on behalf of purchasers of Seadrill Limited (“Seadrill”) (NYSE:SDRL) American Depository Receipts (“ADRs”) during the period of May 28, 2014 to November 25, 2014 (the “Class Period”). Bermuda-based Seadrill is the world’s largest offshore drilling contractor.
Sign-up for TheGrantLawFirm Files Class Action Against Seadrill Limited investment picks
2015/2/3
TheGrantLawFirm, PLLC announces that it has commenced an investigation into a potential fraud class action against Petroleo Brasileiro S.A. - Petrobras (“Petrobras” or the “Company”) (NYSE:PBR) which trades American Depository Receipts (“ADRs”), on behalf of purchasers during the period between May 20, 2010 and November 21, 2014 (“Class Period”). This investigation further focuses on the actions of PricewaterhouseCoopers Auditores Independentes (“PwC”) and PricewaterhouseCoopers International Limited (“PwC-IL”) in connection with the dissemination of materially false and misleading statements by Petrobras in violations of the Securities Exchange Act of 1934 and the Securities Act of 1933 in relation to their audits of Petrobras during the Class Period.
Sign-up for TheGrantLawFirm Investigates Class Action Claims Against Petroleo Brasileiro S.A. – Petrobras and its Auditor PricewaterhouseCoopers Auditores Independentes and PricewaterhouseCoopers International Limited investment picks
2015/2/24
TheGrantLawFirm, PLLC is investigating a potential action on behalf of United Parcel Service, Inc. (“UPS” or the “Company”) for possible breaches of fiduciary duty by the Company’s officers and directors, relating to UPS’s purported failure to comply with federal and state laws.
Sign-up for TheGrantLawFirm, PLLC Investigates United Parcel Service, Inc. for Possible Breaches of Fiduciary Duty investment picks
2015/2/19
http://www.ccnmatthews.com/logos/20051128-ther1.jpg MONTREAL, QUEBEC --
Sign-up for Theratechnologies to Announce Financial Results for Fiscal Year 2014 investment picks
2015/2/6
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1173709&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance Announces FDA Advisory Committee to Review BREO(R) ELLIPTA(R) (FF/VI) for Asthma investment picks
2014/12/3
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1162917&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance Biopharma Announces New Employment Inducement Awards investment picks
2015/1/5
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1167456&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance Biopharma Announces New Employment Inducement Awards investment picks
2015/2/3
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1173008&ProfileId=051205&sourceType=1 GEORGE TOWN, CAYMAN ISLANDS --
Sign-up for Theravance Biopharma Announces New Employment Inducement Awards investment picks
2015/2/24
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1177040&ProfileId=051205&sourceType=1 GEORGE TOWN, GRAND CAYMAN --
Sign-up for Theravance Biopharma Enrolls First Patient in Phase 3 Registrational Study of Telavancin in Staphylococcus Aureus Bacteremia investment picks
2015/2/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1174175&ProfileId=051205&sourceType=1 GEORGE TOWN, GRAND CAYMAN --
Sign-up for Theravance Biopharma Initiates Patient Registry Study for VIBATIV(R) (telavancin) investment picks
2015/2/4
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1173313&ProfileId=051205&sourceType=1 GEORGE TOWN, CAYMAN ISLANDS --
Sign-up for Theravance Biopharma to Present at the Leerink Global Healthcare Conference investment picks
2015/2/2
Phase 3 registrational studies of TD-4208 are anticipated to begin in 2015 GEORGE TOWN, Grand Cayman and PITTSBURGH , Feb.
Sign-up for Theravance Biopharma, Inc. and Mylan Partner to Develop and Commercialize a Novel LAMA Compound, TD-4208, for COPD investment picks
2015/2/18
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1176149&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance Reports Fourth Quarter and Full Year 2014 Financial Results investment picks
2015/2/5
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1173320&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Present at the Leerink Global Healthcare Conference investment picks
2015/2/11
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1174778&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Report Fourth Quarter and Full Year 2014 Financial Results on February 18, 2015 investment picks
2015/2/23
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1177071&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance, Inc. Announces Cash Dividend of $0.25 per Share Payable to Stockholders of Record as of March 12, 2015 investment picks
2015/1/15
Google Inc. (GOOGL) will discontinue its Glass Explorers program on Jan.
Sign-up for There's only four days left to buy Google Glass investment picks
2015/1/29
By Maria Armental Thermo Fisher Scientific Inc. (TMO) is starting to buy back its stock, almost two years after suspending its buyback program ahead of its $13.6-billion acquisition of Life Technologies.
Sign-up for Thermo Fisher Begins Buying Back Stock; Quarterly Results Rise investment picks
2015/2/5
By Michael Calia Thermo Fisher Scientific Inc. said Thursday that it bought Advanced Scientifics Inc. for $300 million in cash.
Sign-up for Thermo Fisher Buys Advanced Scientifics investment picks
2015/1/29
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2014.
Sign-up for Thermo Fisher Scientific Reports Strong Fourth Quarter and Full Year 2014 Results investment picks
2015/2/5
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has acquired Advanced Scientifics, Inc. (ASI), a global provider of single-use technologies for customized bioprocessing solutions, for $300 million in cash.
Sign-up for Thermo Fisher Scientific Strengthens Bioproduction Offering by Acquiring Advanced Scientifics, Inc. investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: The World's Sweetest Game Candy Crush Saga Debuts on Windows Phone to Thermo Fisher Scientific Strengthens Bioproduction Offering by Acquiring Advanced Scientifics, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent